Wellington Management Group
AVXL icon

Wellington Management Group’s Anavex Life Sciences AVXL Stock Holding History

Wellington Management Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-219,090
Closed -$673K – 1936
2026
Q1 		$673K Sell
219,090
-53,141
-20% -$230K ﹤0.01% 1740
2025
Q4 		$969K Sell
272,231
-16,582
-6% -$102K ﹤0.01% 1722
2025
Q3 		$2.57M Buy
288,813
+93,892
+48% +$952K ﹤0.01% 1573
2025
Q2 		$1.8M Buy
194,921
+7,921
+4% +$67.6K ﹤0.01% 1603
2025
Q1 		$1.6M Buy
187,000
+28,326
+18% +$267K ﹤0.01% 1604
2024
Q4 		$1.7M Buy
+158,674
New +$1.22M ﹤0.01% 1609

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group's AVXL Position: Q2 2026 in Review

Wellington Management Group sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 219,090 shares — an estimated $673K sold.

Wellington Management Group first reported a position in AVXL in Q4 2024 and held it in 6 quarters. The position peaked at $2.57M in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Wellington Management Group reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Wellington Management Group sold 219,090 Anavex Life Sciences shares in Q2 2026, an estimated $673K.
  • Wellington Management Group first reported a position in Anavex Life Sciences in Q4 2024 and held it in 6 quarters.
  • Wellington Management Group's Anavex Life Sciences position peaked at $2.57M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.